The recommended interval between the two doses of Covishield, manufactured by Pune’s Serum Institute of India, was increased from four-six weeks to six-eight weeks in April.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.